Seeing Is Believing

Currently out of the existing stock ratings of Yaron Werber, 137 are a BUY (72.87%), 50 are a HOLD (26.6%), 1 are a SELL (0.53%).
Analyst Yaron Werber, currently employed at TD COWEN, carries an average stock price target met ratio of 63.32% that have a potential upside of 23.17% achieved within 351 days.
Yaron Werber’s has documented 373 price targets and ratings displayed on 40 stocks. The coverage is on Healthcare, Consumer Defensive sectors.
Most recent stock forecast was given on ROIV, Roivant Sciences Ltd at 09-Sep-2026.
Analyst best performing recommendations are on GMAB (GENMAB AS).
The best stock recommendation documented was for ARGX (ARGENX NV ADR) at 7/17/2023. The price target of $533 was fulfilled within 3 days with a profit of $48.57 (10.03%) receiving and performance score of 33.42.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 06-Sep-2023
$425
$10.39 (2.51%)
$320
20 days ago
(10-Sep-2026)
1/2 (50%)
$42.53 (11.12%)
797
Hold Since 07-Oct-2024
$400
$-14.61 (-3.52%)
$400
22 days ago
(08-Sep-2026)
32/35 (91.43%)
$6.83 (1.74%)
269
Buy Since 12-Apr-2024
$450
$35.39 (8.54%)
$450
22 days ago
(08-Sep-2026)
32/34 (94.12%)
$56.83 (14.45%)
567
Hold Since 10-Jan-2025
$435
$20.39 (4.92%)
$400
26 days ago
(04-Sep-2026)
20/21 (95.24%)
$-2.23 (-0.51%)
307
Buy Since 02-Jan-2025
$457
$42.39 (10.22%)
$427
1 months 10 days ago
(20-Aug-2026)
14/15 (93.33%)
$25.79 (5.98%)
160
Which stock is Yaron Werber most bullish on?
Which stock is Yaron Werber most reserved on?
What Year was the first public recommendation made by Yaron Werber?